Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose

Siri Shastry1, Ishak Nobel2, Lisa R Allen1

  • 1Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.

Abstract

Insights

Medications for opioid use disorder (MOUD) prescriptions increased, but misuse was noted with methadone. Prior buprenorphine use was linked to shorter opioid overdose (OD) lengths of stay.

Area of Science:

  • Emergency Medicine
  • Addiction Medicine
  • Pharmacology

Background:

  • Medications for opioid use disorder (MOUD) are crucial for reducing opioid overdose (OD) mortality.
  • The prevalence and misuse patterns of MOUD among emergency department (ED) patients presenting with OD are not well-understood.
  • The impact of existing MOUD prescriptions on subsequent OD severity requires further investigation.

Purpose of the Study:

  • To determine the prevalence and trends of MOUD use in ED patients with opioid overdose.
  • To investigate the misuse of different MOUD formulations in this patient population.
  • To assess the association between prior MOUD prescriptions and OD severity, including length of stay (LOS) and in-hospital mortality.

Main Methods:

  • A prospective observational cohort study was conducted involving ED patients with confirmed opioid overdose at two tertiary-care hospitals between 2015 and 2019.
  • Patients were included based on confirmed opioid OD via urine toxicology; exclusions included alternate diagnoses, insufficient data, age < 18, and prisoners.
  • Opioid overdose severity was measured by hospital LOS and in-hospital mortality. Time trends and associations between MOUD and outcomes were analyzed.

Main Results:

  • Of 696 patients with confirmed opioid OD, 17% had a prior MOUD prescription, with prevalence increasing significantly from 2016 to 2019.
  • Methadone showed higher odds of misuse (OR 3.96) compared to buprenorphine (OR 1.16).
  • Patients on buprenorphine had significantly shorter LOS (IRR -0.44) after adjustment. While any MOUD was associated with lower odds of death (OR 0.70), methadone had the highest odds (OR 0.82).

Conclusions:

  • MOUD prevalence in ED patients with opioid overdose significantly increased during the study period.
  • Misuse was observed, particularly with methadone, while buprenorphine was associated with reduced hospital LOS.
  • These findings highlight the evolving landscape of MOUD use and its varied impact on OD outcomes in the ED setting.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
514
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
457
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
932
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
797
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
901
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.4K